Objective: To perform a retrospective clinico-pathological and immunohistochemical analysis of malignant melanomas. Methods: One-hundred sixty consecutive cases diagnosed in the Department of Pathology of the County Emergency Clinical Hospital of Tîrgu Mureș, Romania, between January 2000 -December 2009, were used. Of these, 47 cases were melanoma metastases that were excluded from the study; this research was focused on the study of 113 primary melanomas (PMs). In 20 cases of PMs (11 cutaneous, 5 choroidal, and 4 melanomas of the anal canal) immunohistochemical stains were performed using the antibodies p53, Ki67, ER (estrogen receptor), CD8 and CD31. Results: Cutaneous PMs prevailed (83%) followed by choroidal (11%), digestive tract (4%) and nasal mucosa PMs (2%). Independent of their location, PMs predominantly affected females (58%) over age 50. Regarding cutaneous cases, lower limbs (49%) were more affected, followed by the head and neck (18%) and the trunk (18%). We noted negativity or low p53-nuclear positivity in cutaneous and digestive tract PMs; p53 was overexpressed in choroidal melanomas. On the other hand, although the proliferative index Ki67 was also quite low in cutaneous PMs, its percentage increased in choroidal and digestive tract PMs. CD8 was positive in cutaneous PMs and negative in choroidal and digestive tract cases. While in cutaneous PMs we noted a predominated angiogenesis by intussusception, in digestive tract melanomas there was a predominance of sprouting and pseudoglomeruloid mechanisms. Conclusions: Choroidal PMs display the highest p53 and Ki-67 expression, compared to cutaneous MMs. Tumor angiogenesis seems to present a specifi c pathway in cutaneous PMS compared to the gastrointestinal cases. 
Introduction
In most of the cases, malignant melanomas (MMs) aff ect the skin, but they can be also located in the choroid, nasal cavity, gastrointestinal and even the urogenital tract [1] [2] [3] [4] [5] [6] [7] . Despite the newest targeted drugs, such as monoclonal BRAF-inhibitors, MM remains the most deadly malignant tumor of the skin, with an increasing incidence [8] . It predominantly aff ects Caucasians, being uncommon in black people and Asians. Several risk factors were identifi ed, such as genetic predisposition, ultraviolet irradiation, family history, dysplastic nevi [9, 10] . Th e diagnosis of non-cutaneous MMs is diffi cult; it requires a correct differentiation from metastases, undiff erentiated carcinomas and other mesenchymal tumors.
Th e aim of this paper is to present clinico-pathological data of MMs diagnosed in our laboratory and to present the preliminary results regarding some immunohistochemical examinations. Th e mechanisms of angiogenesis, the process of formation of new vessels from pre-existing blood vessels, were also analyzed.
Methods
Surgical specimens from 160 consecutive MM cases, diagnosed in the Department of Pathology of the County Emergency Clinical Hospital of Tîrgu Mureş, Romania, between January 2000 -December 2009, were enrolled in the study. Of these, 47 were metastases, which were eliminated from the study, our research focusing on the remaining 113 cases of primary melanomas (PMs).
For each of the cases, the patient's gender and age, tumor location and the recurrence rate were analyzed. For cutaneous PMs, the histological type, Breslow index and tumor stage were also examined.
Th e statistical analysis was performed using the GraphPad InStat 3 programme. A signifi cant association was considered when p <0.05, with a 95% confi dence interval.
Immunohistochemical staining
Th e immunohistochemical stains were performed in 20 randomly selected cases of PMs (11 cutaneous, 5 choroidal and 4 melanomas of the anal canal). To confi rm the diagnosis, the antibodies anti-HMB45 (clone MS364, dilution 1:50) and S-100 protein (polyclonal rabbit, dilution 1:6000) from LabVision were used. We also performed immunohistochemical stains with a panel of fi ve antibodies provided by LabVision: p53 (clone DO-7, dilution
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Th e immunohistochemical stains were performed on paraffi n-embedded tissues, using the UltraVision System (LabVision). Th e heat-induced antigen retrieval was performed in high-retrieval solution for CD31 and citrate solution for the other antibodies. Th e slides were developed using diaminobenzidine (DAB; Dako) and counterstained with Mayer`s hematoxylin. For negative controls, incubation was performed with omission of the specifi c antibodies.
Interpretation of immunohistochemical stains
For anti-p53, Ki67 and Estrogen Receptor (ER) antibodies, the average percentage of the positive nuclei was quantifi ed in the tumor cells, a cut-off value of 10% being considered.
For anti-CD8 antibodies we determined the number of intratumoral T-cells (intratumoral lymphocytic infi ltrate), at a 200× magnifi cation.
Angiogenesis was quantifi ed using anti-CD31 antibodies and a Nikon E800 microscope, equipped with a video camera. To determine microvessel density (MVD), we identifi ed the intratumoral areas with the most intense vascular density ("hot spot areas") and captured digital images from these regions, at 400 high power fi elds. In these areas, we counted the number of neoformed vessels (MVD). Both individual endothelial cells and vessels with lumen were taken into account. Th e ulcerated zones and areas with a high amount of infl ammatory infi ltrate were eliminated. Th e mechanisms of angiogenesis were analyzed, based on the arhitecture of the tumor cells. Endothelial sprouting, vessel co-option, intussusception, pseudoglomeruloid pattern and vasculogenic mimicry were explored, based on the previously well-known classifi cations [11] .
Results

Clinicopathological data
Of 113 patients with PMs, 58% were females and 42% males. Th e average age was 60.59 ± 14.32 years. Female patients had an average age of 60.11 ± 15.03 years and males 61.23 ± 13.39 years, without a statistically signifi cant difference (p = 0.62). Th e incidence of melanomas increased, in both genders, over the age of 50 years.
Most of the cases were cutaneous PMs (94 cases) followed by choroidal (12 cases), anal canal (5 PMs) and nasal mucosa PMs (2 cases) ( Figure 1 ).
Both melanomas of the nasal mucosa were diagnosed in females and of the 12 choroidal melanomas, 9 cases were diagnosed in male patients (19.14% of all melanomas), and 3 in female patients (4.54% of all melanomas). Th e proportion of cutaneous and gastrointestinal melanomas had a relatively equal distribution among genders.
Particularities of cutaneous PMs
Independently by the patient's gender, the lower limbs (49%) were more aff ected, followed by the head and neck (18%), trunk (18%) and the upper limbs (15%). In females, PMs occurred mostly on the lower limbs (49%) followed by the trunk (21%); in males, the trunk (35%) was the most common location, followed by the lower limbs (30%) (Figure 2 ). More than 2/3s of the 94 cutaneous PMs were nodular (78%), followed by superfi cial (16%) and lentiginos-type melanoma (6%). Most of these tumors presented invasion of the reticular dermis (49%), regardless of location, age and gender. Th e microscopic type of melanomas was not correlated with the depth of invasion (p = 0.45), but nodular tumors had a larger diameter than superfi cial PMs (p = 0.015).
Th e average diameter was 5.96 ± 2.34 mm (ranging between 0.4-30 mm). In females the average diameter was 5.11 ± 1.54 mm; in males, it was slightly higher 7.65 ± 3.21 mm, with a diff erence at the limit of statistical signifi cance (p = 0.05). Th e tumor size was not correlated with the patient's age or the localization of cutaneous PMs (p= 0.52). However, all PMs larger than 15 mm presented invasion of the hypodermis and subcutaneous tissues (p <0.01).
In the analyzed material, the Breslow index increased in parallel with the depth of invasion (p= 0.002). In terms of Clark level, statistical diff erences regarded the pT4 and pT1 stages (p= 0.001). Th us, all melanomas with Clark level V were diagnosed in stage pT4 and invasion limited to the epidermis was observed only in melanomas ≤1 mm, namely those diagnosed in stage pT1. Regarding pTNM staging, most of the cutaneous PMs were diagnosed in stage pT4 (53%) followed by stages pT3 (21%), pT1 (10%) and pT2 (20%).
Correlation of microscopic aspects with recurrence/ metastasis rate
From 113 PMs, regardless of location, 14 (12.38%) presented recurrence and/or metastasis. Out of 14 patients, 13 were females and one male. In 12 cases, the primary tumor was cutaneous-located, the metastases being identifi ed in the liver and brain. One esophageal PM presented a cutaneous metastasis, and a nasal mucosa PM recurred.
The immunohistochemical features
ER, p53 and Ki67 expression
None of the 20 cases expressed ER.
In cutaneous PMs, we noted negativity or low expression of the p53 protein (<20%), regardless of tumor stage, presence/absence of recurrences/metastasis. PMs of the digestive tract did not express p53. In choroidal melanomas, p53 was overexpressed, being identifi ed in more than 50% of the nuclei of tumor cells.
Th e proliferative index Ki67 was low in cutaneous PMs, in most of cases being expressed in <5-10% of the tumor cell nuclei. In choroidal melanomas, the average index of Ki67 positivity was about 25%. In PMs of the digestive tract, its average value was 75% (Figure 3 , Table I ). Th ere were no correlations between p53 and Ki67 expression.
Angiogenesis and CD8 expression in cutaneous PMs
Th e average number of intratumoral vessels, marked by CD31 (MVD), was 3.21 ± 1.23, independent of the microscopic type, Breslow index, Clark level or other clinico-pathological factors. Angiogenesis by intussusception was the predominant mechanism observed in the 10 PMs, most of the vessels being large, with well-defi ned lumen (Figure 3 ).
An interesting aspect was observed regarding the correlation between CD31 and TIL value, quantifi ed with CD8. In most of the cases, 2-3 CD8-positive TILs were identifi ed at the 200× magnifi cation. In these cases, a few mature vessels (1-2/fi eld, HPF) with well-defi ned lumen were observed. On the other hand, in those cases that displayed a higher number of TILs (over six per microscopic fi eld), neoformed vessels were also present in a signifi cant number, with the predominance of isolated endothelial cells or well-defi ned vessels with a thin wall and very small lumen.
Angiogenesis and CD8 expression in choroidal PMs
Despite of a high p53 index in choroidal melanomas, there were no intratumoral lymphocytes (CD8 was negative) and angiogenesis was extremely low, only one or two fully mature, large vessels were rarely observed.
Angiogenesis and CD8 expression in PMs of the digestive tract (anal canal)
In all four cases located in the anal canal, CD8 was negative, but angiogenesis was intense, with the predominance of isolated endothelial cells or well-defi ned vessels with thin wall and very small lumen. Sprouting angiogenesis and pseudo-glomeruloid pattern predominated ( Figure 3 ).
Discussion
In the light of our results, which showed a slight predominance of females compared to males (M:F = 1:1.2) and the predominance of lower limb cutaneous PMs in females, and trunk PMs in males, respectively, there are authors who revealed the importance of sunlight exposure in the pathogensis of PMs of the skin [12] . Apart from the skin and choroidal plexus, primary malignant melanomas are rare at the other sites, these being reported in the literature mainly as case presentations [3, 5, 7] . Th e prognosis of cutaneous PM depends on the microscopic type of tumor (nodular vs. superfi cial), Breslow index, presence of ulceration, the status of sentinel lymph nodes and tumor stage [9, [13] [14] [15] [16] . In our study, an average tumor diameter of 5.96 mm was described, all tumors over 15 mm being diagnosed in the pT4 stage; therefore, pTNM stage remains the most important prognostic criterion.
Th ere are several recent studies that highlight the importance of various antibodies and molecular examinations to predict the prognosis of PMs. One of this marker, undetected in our cases, is ER . Th ere is a supposition about its role in the progression of cutaneous PM; some authors proved a progressively decreasing expression of ER at the same time with the increase of Breslow index and tumor stage, respectively [17, 18] .
Both p53 and Ki67 were poorly expressed in cutaneous PMs, but choroidal PMs showed intense p53 nuclear positivity. Nuclear Ki67 proliferation index was increased in PMs located in the anal canal, but it was not correlated with p53 expression in any of the locations. However, overexpression of Ki67 is associated with lower survival rates [19] .
An important topic in the fi eld of melanoma research is related to angiogenesis; it can be inhibited using antiangiogenic substances, but the results are below expectations; a proper inhibition might make tumors highly susceptible to other chemotherapics [20] . Th e mechanisms of angiogenesis still remain unelucidated. Although previous studies revealed that the vessels co-option is the most commonly involved mechanism [21] , intussusception was the angiogenic pattern observed in our material, in cutaneous PMs; a pseudo-glomeruloid angiogenesis was marked out by the PMs of the anal canal. No other studies showed the presence of these possible mechanisms in melanoma pathogenesis.
Conclusions
Diverse angiogenic mechanisms and features of agressivity are present in cutaneous melanomas, compared to choroidal and gastrointestinal primary melanomas. Intussusception angiogenesis seems to predominate in cutaneous melanomas, but the pseudo-glomeruloid pattern is rather characteristic for melanomas of the anal canal. A proper understanding of the mechanisms of angiogenesis involved in the pathogenesis of melanoma should be explored in further studies, as a possible cause of resistance to antiangiogenic therapy.
